TNFSF15 inhibits progression of diabetic retinopathy by blocking pyroptosis via interacting with GSDME

Hongkun Zhao1, Yating Dai2, Yunqin Li1

  • 1Key Laboratory of Yunnan Province, Yunnan Eye Institute, Affiliated Hospital of Yunnan University, Yunnan University, Kunming, Yunnan, China.

Cell Death & Disease
|February 8, 2024
PubMed

Insights

TNFSF15 inhibits diabetic retinopathy by blocking GSDME-mediated pyroptosis in retinal cells. This interaction presents a potential therapeutic target for preventing vision loss in diabetic patients.

Area of Science:

  • Ophthalmology
  • Cell Biology
  • Endocrinology

Background:

  • Diabetic retinopathy (DR) is a leading cause of blindness, driven by microvascular complications of diabetes.
  • Pyroptosis, a pro-inflammatory cell death pathway, plays a significant role in DR pathogenesis.

Purpose of the Study:

  • To investigate the role of Gasdermin E (GSDME)-mediated pyroptosis in DR.
  • To explore the regulatory mechanism of TNFSF15 on GSDME-mediated pyroptosis in the context of DR.

Main Methods:

  • Analyzing GSDME expression in DR progression.
  • Investigating the effect of high glucose on pyroptosis in retinal cells.
  • Identifying TNFSF15 as a GSDME binding partner and inhibitor.
  • Assessing TNFSF15's effect on high glucose- and Raptinal-induced pyroptosis.

Main Results:

  • GSDME was upregulated during DR progression.
  • High glucose induced GSDME-mediated pyroptosis in retinal cells via caspase-3 activation.
  • TNFSF15 expression increased with high glucose but was suppressed by Raptinal.
  • TNFSF15 inhibited pyroptosis by interacting with GSDME in retinal cells.

Conclusions:

  • TNFSF15 acts as an inhibitor of GSDME-dependent pyroptosis in retinal cells.
  • The TNFSF15-GSDME interaction is a promising therapeutic target for inhibiting diabetic retinopathy progression.

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
66
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
52
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
99